MiniMed™ 770G System Insulin Pump Technology

Real- World Outcomes With SmartGuard™ Auto Mode Technology

Learn more

The MiniMed 770G system including pump, sensor, transmitter, and mobile app.

Alert Important Safety Information

Overview

The MiniMed™ 770G insulin pump system helps your patients focus more on their daily life.

Automation

Automatically adjusts insulin delivery every 5 minutes
To help your patients prevent highs and lows*

Increased Time in SmartGuard Auto Mode^†
Compared to MiniMed™ 670G¹system

Improved MiniMed™ 770G Customer Experience
Compared to MiniMed™ 670G²system

Connectivity

Patients can automatically upload their insulin and CGM data directly from their smartphone for easier patient care

Patients get notified on their phone
If they’re going high or low

CareLink™ Connect App
Data can be shared with up to 5 Care Partners

Support

Always by your side
Largest global support team in the industry with 24/7 service

My Insights
Providing insights & encouragement based on CareLink™ observations

Medtronic data on file: MiniMed ™ 770G and MiniMed™ 670G data uploaded voluntarily by 59,333 users in the US to CareLink™ Personal, from Nov 2020 to 8 Aug 2022

Medtronic data on file: NPS satisfaction scores FY22Q4 MiniMed™ 770G vs 670G users, 30th July 2022

Enabled for future software upgrades

Any customer using the MiniMed^TM 770G system will get access to our next technology, when available, at no cost.^‡

Our next innovation goal is to reduce fingersticks and bring you an advanced algorithm with auto-correction bolus for easier mealtimes. Get access to the future by filling out the form below and learning more about the MiniMed^TM770G system.

Learn more about our future innovations.

Real-world outcomes

87.5%

Time in
SmartGuard^TM
Auto Mode¹

156.2
mg/dL

Mean sensor
glucose¹

7.0%

Mean Glucose
Management Indicator
(GMI)¹

Medtronic data on file: MiniMed ™ 770G and MiniMed™ 670G data uploaded voluntarily by 59,333 users in the US to CareLink™ Personal, from Nov 2020 to 8 Aug 2022
Due to inherent analysis limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences.

SmartGuard™ Auto Mode

Impacts to Time in Range during the night¹

Three graphs comparing the average nighttime time in range of patients.

Patients included in analysis must meet the following criteria: At least 10 days of sensor data after the SmartGuard™ initiation periods

Medtronic data on file: MiniMed™ 770G and MiniMed™ 670G data uploaded voluntarily by 11,231 users in the US to CareLink™ Personal with >10days of pre and post data from Nov 2020 to 8 Aug 2022. Due to inherent analysis limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences.

Minimed™ 770G System overview

To help keep your patients in safe range

Expand All

1. Insulin pump

2. Infusion set

3. Continuous glucose monitor (CGM)

4. Smartphone apps

The components of the MiniMed 770G insulin pump system shown on the body.

Automatic CareLink™ data uploads

Enabling meaningful patient conversations

Two images showing a physician and patient looking at CareLink data on a tablet.

TheMiniMed™ 770G system with Bluetooth^® connectivity enables automatic CareLink™ uploads, helping support meaningful conversations with your patients, whether in-person or via telehealth.

No more last-minute pump uploads

Convenient

Your patients’ data can now be easily uploaded prior to their appointments.

Actionable

Providing access to insights for your patients’ therapy adjustments.

Available 24/7

Giving you and your patients the ability to view data whenever needed.

Smartphone connectivity enables new features

Helping your patients and their families live more and worry less.

MiniMed™ Mobile app

Your patients can now use their smartphones to view their data. This means they can easily and discreetly track their glucose levels and get notified of highs and lows.

CareLink™ Connect app

Available for care partners, this app helps keep everyone in the loop. Up to five care partners can now follow a pump user and receive high and low notifications.

Expand All

Technical Specifications

Specifications
Water Resistance	At the time of manufacture and when the reservoir and tubing are properly inserted, your pump is waterproof. It is protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours. This is classified as IPX8 rating. See user guide for more details. The sensor and transmitter are water-resistant at 8 feet (2.4 meters) for up to 30 minutes. CGM readings may not be transmitted from the CGM to the pump while in water.
Environmental Conditions	The MiniMed™ 770G insulin pump system is designed to withstand most conditions encountered in your daily life. Pump storage temperature range is from -4°F (-20°C) to 122°F (50°C). Air pressure range is from 700 hPa to 1060 hPa (10.2 psi to 15.4 psi).
Altitude Range	Pump operating range is from 10.2 psiA (70.33 kPa) to 15.4 psiA (106.18 kPa) Storage range is from 7.2 psiA (49.64 kPa) to 15.4 psiA (106.18 kPa)
Insulin Type	Rapid-acting U100 insulin (Humalog^®and NovoLog^®) that has been prescribed by a healthcare professional.
Bolus Delivery	Bolus Speed Standard: 1.5 units/minute Quick: 15 units/minute Programming Increments 0.025 units 0.05 units 0.1 units
Basal Rate Delivery	0 to 35 units per hour or the Max Basal Rate amount, whichever is lower.
Screen	Color screen with auto-brightness Backlight time out 15 seconds (default), 30 seconds, one minute, three minutes
Battery & Power	The pump requires one new AA (1.5 V) battery. For best results, use a new AA lithium (FR6) battery. The pump also accepts an AA alkaline (LR6) or a fully charged AA NiMH (HR6) nickel-metal hydride rechargeable battery.
Pump Memory	At any time you can review 90 days of pump history.
Size	The pump dimensions in inches are approximately 2.1 width x 3.78 length x 0.96 depth. The weight of the pump is approximately 3 ounces.
Warranty	Insulin Pump: 4 years. Replacement warranty could be up to 5 years for some insurance CGM transmitter: 1 year

Compatible Products

Compatibility
Reservoir	Medtronic reservoir MMT-332A, 3.0 ml (300-unit)
Infusion sets	Medtronic Diabetes provides a variety of infusion sets to fit your patients' needs.
Guardian™ Link 3 Transmitter	Used with the sensor for continuous glucose monitoring (CGM). This device connects to a glucose sensor. It collects data measured by the sensor and wirelessly sends this data to monitoring devices.
Guardian™ Sensor 3	Used with the transmitter for CGM. The sensor is a small part of the continuous glucose monitoring system that is inserted just below the skin to measure glucose levels in interstitial fluid.
Accessories	There are many ways to wear an insulin pump. Your patients can attach your pump to their waistband or belt, protect it in their pocket, or even clip it under their clothing. See our collection of accessories here.
Accu-Chek^® Guide Link Blood Glucose Meter	The MiniMed™ 770G system comes with a compatible meter. Accurate test results are sent wirelessly to the pump for quick sensor calibration.

Request more information

Complete the form below and a representative will follow up with additional information.

This form is for Healthcare Professionals. If you are a patient looking for more information click here

* Indicates a required field.

I agree to receive emails from Medtronic Diabetes.*

I have read and agree with the Terms and Conditions*

Your information will be used and protected in accordance with our privacy statement.

Refers to SmartGuard™ Auto Mode. Some user interaction required. Induvial results may vary.

^†

Based on real world evidence comparing 54,009 MiniMed™ 670G users vs. 59,333 MiniMed™ 770G users. Due to inherent analysis limitations, caution is advised when attempting to extrapolate these results to new patients. There could be significant differences.

^‡

Software Upgrade Terms and Conditions

This program allows MiniMed™ 770G system users a software upgrade at no charge within one year from the date of this software approval. Software approval will be announced.
Software upgrade process is subject to change. The process may result in healthcare provider office visit and may result in out-of-pocket expenses such as co-pay, depending on insurance coverage. The process may require the completion of product related training.
This program includes the insulin pump software only. CGM products and consumables are not included in this offer.
Warranty dates do not reset. The replacement warranty date of an insulin pump upgraded with the software will remain the same as the replacement warranty date of the initial pump purchased. Your warranty date does not impact eligibility for a software update.
MiniMed™ pumps and software have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider regarding your eligibility to receive the software upgrade based on the labeling of the upgrade, which may differ from the labeling of the MiniMed™ 770G pump.
Insurance coverage and plan design varies and may impact the ability to upgrade. Coverage is contingent upon your health insurance medical policy guidelines. Restrictions and medical necessity requirements may apply.
A valid prescription will be required for this software upgrade. All participants should consult their healthcare provider for all therapy related decisions.
Program terms and conditions are subject to change at any time and without notice. Other restrictions may apply.

Important Safety Information: MiniMed^TM 770G System with SmartGuard^TM Technology

The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose (SG) values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G system consists of the following devices: MiniMed™ 770G insulin pump, the Guardian™ Link (3) transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu-Chek® Guide test strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.”